Table 1 of Khan, Mol Vis 2010; 16:2146-2152. Table 1 of Khan, Mol Vis 2010; 16:2146-2152.
Table 1. Overall and gender segregated data of GST genotypes in unaffected controls and PEXG patients.
| Group | Genotype | Controls | Patients | p (χ2) | p (χ2) | pb | ps | OR (95% CI) |
|---|---|---|---|---|---|---|---|---|
| Total | T1M1 | 95 (59%) | 57 (34.5%) | <0.001 (21.82) | Reference | |||
| T1M0 | 51 (31%) | 69 (41%) | 0.001 (10.79) | <0.05 | <0.05 | 2.25 (1.34–3.79) | ||
| T0M1 | 9 (6%) | 23 (14%) | <0.001 (12.71) | <0.001 | <0.001 | 4.26 (1.73–10.74) | ||
| T0M0 | 7 (4%) | 16 (9.5%) | <0.05 (8.45) | <0.05 | <0.05 | 3.81 (1.37–10.96 | ||
| Total | 162 | 165 | ||||||
| Females | Genotype | Controls | Patients | p (χ2) | p (χ2) | pb | ps | OR (95% CI) |
| T1M1 | 60 (80.5%) | 26 (33.8%) | <0.001 (35.63) | Reference | ||||
| T1M0 | 16 (20.8%) | 31 (40.2%) | <0.001 (15.84) | <0.001 | <0.001 | 4.47 (1.96–10.29) | ||
| T0M1 | 1 (1.2%) | 9 (11.7%) | <0.001 (13.81) | <0.001 | <0.001 | 20.77 (2.45–460.38) | ||
| T0M0 | 0 (0%) | 11 (14.3%) | <0.001 (20.12) | <0.001 | <0.001 | N/A | ||
| Total | 77 | 77 | ||||||
| Males | Genotype | Controls | Patients | p (χ2) | p (χ2) | pb | ps | OR (95% CI) |
| T1M1 | 35 (41.2%) | 31 (35%) | >0.05 (2.28) | Reference | ||||
| T1M0 | 35 (41.2%) | 38 (43%) | >0.05 (0.36) | >0.05 | >0.05 | 1.23 (0.60–2.52) | ||
| T0M1 | 8(9.4) | 14 (16%) | >0.05 (1.83) | >0.05 | >0.05 | 1.98 (0.66–6.01) | ||
| T0M0 | 7 (8.2%) | 5 (6%) | >0.05 (0.11) | >0.05 | >0.05 | 0.81 (0.20–3.24) | ||
| Total | 85 | 88 |